Home Agenda Archief Netwerk Nieuws | News Symposia Werkgroep

Program Abstracts Posters Submission Slides Hotels Directions
|
FABIAN 2009
Socially
Responsible Bioanalysis
10 November 2009, Solvay
Pharmaceuticals, Weesp
|
To submit a poster follow the instructions on
submissie.htm
|
Poster Title |
Abstract
|
|
Radioactive
measurement: Combustion or Dissolving - Radioactive measurement of feces, blood,
liver, brain or fat tissue, a Comparison of Dissolving with Combustion
E. Beek-van Velzen (Solvay Pharmaceutical
Research Laboratories, C.J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands)
|
09P01
|
|
Bioanalytical Method
Development for Therapeutic Peptides
Erin Chambers (Waters Corporation)
|
09P02
|
|
A Leap Forward in
Sensitivity and Selectivity for PAH Analysis using GC-APLI-TOF/MS
Rob van der Heijden1, Patrick
van Houts1, George McLeod2, Thomas Arthen-Engeland3,
Carsten Baessmann3, Armin Holle3 (1. Bruker Daltonics BV, PO Box 88, 1530 AB, Wormer, The Netherlands,
2. Bruker Daltonics, Coventry, United Kingdom and
3. Bruker Daltonik GmbH, Bremen, Germany)
|
09P03
|
|
Improved Peptide
Identification with an Ultra High Resolution Quadrupole Time of Flight MS (maXis)
Patrick van Houts1, Rob van der
Heijden1, Markus Lubeck2, Marina Behrens2,
Andrea Schneider2, Carsten Baessmann2 and Oliver Raether2
(1. Bruker Daltonics, Wormer, The Netherlands and 2. Bruker Daltonik, Bremen, Germany)
|
09P04
|
|
Detection of
Metabolites in Urine at Microdosing Levels in Rats Using LC-MS/MS
Carmai Seto1, Tanya Gamble1,
Takeo Sakuma1, Jinsong Ni2, Fred Ouyang2, Devin
Welty2 and Andrew Acheampong2 (1. Applied Biosystems/MDS Analytical Technologies, 71 Four Valley Drive, Concord,
Ontario, Canada and
2. Dept of Drug Safety Evaluation, Allergan, Irvine, CA, USA)
|
09P05
|
Increased Selectivity
Without Loss of Sensitivity: Use of LC-MS3 for Sensitive Additional Structure
Information and LC-MRM3 for Highly Selective Quantification
Axel Besa and Jan Lembcke (Applied Biosystems Germany, Frankfurter Straße 129 B, 64293 Darmstadt, Germany)
|
09P06
|
|
High Throughput
Screening of GSH Adducts Using Hybrid Linear Ion Trap Systems Coupled with Fast
Chromatography at Clinically Relevant Dose Concentrations
Hua-fen Liu1, Hesham Ghobarah2
, Renee Huang1, Jens Dahlmann3 and Elliott Jones1
(Applied Biosystems, part of Life Technologies, (1) Foster City, USA, (2)
Concord, Canada, (3) Darmstadt, Germany)
|
09P07
|
|
Simultaneous
quantification of testosterone and androstenedione in human serum using LC-MS/MS
E. Joos1,2, J. Van Bocxlaer2, M. Vandermarliere1
and K. Croes1 (1. Clinical Laboratory, AZ Groeninge, Reepkaai, B-8500 Kortrijk. Belgium
&
2. Laboratory for Medical Biochemistry and Clinical Analysis, Fac. Pharm. Sci.,
Ghent University, Harelbekestraat 72, B-9000 Gent. Belgium)
|
09P08
|
|
CHIRAL LC-MS-MS
DETERMINATION OF (R)- AND (S)-CITALOPRAM IN HUMAN PLASMA SAMPLES
E. Mallat, V. Jas, J. Flik, M. Boterman,
K. de Jonge (Analytisch Biochemisch Laboratorium (ABL) BV, Scholtenstraat 7, Assen, The
Netherlands)
|
09P09
|
|
A sensitive LC-MS/MS
method for the separate quantification of gentamicin C1, C1a, C2 and C2a in
bovine tissue.
M. Boterman, M.J. Dröge, F. Oostebring, F. Venema
& E. Oosting (Analytisch Biochemisch Laboratorium (ABL) BV, Assen, The Netherlands)
|
09P10
|
|
A sensitive automated online SPE-LC-MS/MS
method for the quantitative determination of ivermectin B1a in bovine plasma.
M. Boterman1, M.J. Dröge1,
F. Oostebring1, M.A.H. Boezeman2 and E. Oosting1
(1. Analytisch Biochemisch Laboratorium (ABL) BV, Assen, The Netherlands and 2. Farma Research Animal Health (FRAH) BV,
Nijmegen, The Netherlands)
|
09P11
|
|
New UHPLC systems from Eksigent
Technologies for improved performance in LC/MS
Rein Reitsma (Separations Analytical Instruments)
|
09P12
|
|
DRIED BLOOD SPOTS FOR
TK/PK AND BIOMARKER ANALYSIS AND 3R
Elwin Verheij (TNO Quality of Life, PO Box 360, 3700
AJ Zeist)
|
09P13
|
|
Generic solid phase extraction
procedure for the quantitative analysis of peptides in plasma
H. Korthals, H. Gerritsen, R. Brust-van Schaik
and B. Buscher* (TNO Quality of
Life, Zeist, The Netherlands)
|
09P14
|
|
EX VIVO HUMAN SKIN MODEL FOR PHOTOGENOTOXICITY TESTING
AA Reus,
FAA van Acker, CAM Krul (TNO Quality of Life, Zeist, The Netherlands)
|
09P15
|
|
Monitoring Matrix
EffectsM in Biological Samples Utilizing Dual Scan MRM Mode Mass Spectrometry
Paul D Rainville, Joanne Mather, Robert S Plumb,
Jing Lin (Waters Corporation, Milford, MA)
|
09P16
|
|
The CMA 64 IView
microdialysis Catheter
Noud Grimberg (Aurora Borealis Control B.V.,
Postbus 2, 7760 AA Schoonebeek)
|
09P17
|
|
Accuracy of incurred
sample results, the final validation challenge in quantitative bioanalysis ?
Theo de Boer, Marjan Hagenouw, Rudy Francke and
Jaap Wieling (Xendo Drug Development B.V., Hanzeplein 1, NL-9713 GZ Groningen,
The Netherlands)
|
09P18
|
|
Application of Dried
Blood Spot sampling within clinical trials: Feasibility study of pardoprunox, a
potent anti-Parkinson Drug
O.A.M. Brockhoff1, P.H. van Amsterdam1,
J. Thomson2, C. Troupe3 (1. Solvay Pharmaceuticals, Global
Bioanalytics Department, Weesp, The Netherlands 2. Aptuit Inc, Riccarton,
Scotland, 3. Quintiles Laboratories, Marietta, GA, USA)
|
09P19
|
|